The Liver Transplant Patient Part 1: Managing Adults with Cirrhosis
نویسندگان
چکیده
Hospital Physician March 2007 19 O rthotopic liver transplantation is a surgical procedure in which the diseased native liver is removed and replaced with all or part of a healthy liver obtained from a deceased or living human donor. The first liver transplantation was performed in 1963. Initially, overall outcomes were poor and liver transplantation remained experimental. Following advances in immunosuppression in the late 1970s, survival improved dramatically, and in the mid1980s, liver transplantation began to move into the mainstream of clinical practice. Liver transplantation today is the established standard of care for many patients with end-stage liver disease. In 2005, more than 6400 liver transplants were performed in the United States at 119 sites.1 Transplantation is carried out in tertiary centers by teams of specialists experienced in caring for patients with advanced liver disease, performing transplant surgery, and managing posttransplant immunosuppression. However, every physician can expect to encounter liver transplant patients in clinical practice and should be familiar with some basic aspects of evaluation and management. This article is part 1 of a 2-part series on medical care of adults before and after liver transplantation. Part 1 discusses the primary care physician’s role of identifying patients with liver disease who may require liver transplantation and optimizing management of liver disease while the patient awaits transplantation. Part 2, to be published in the April 2007 issue of Hospital Physician, will review liver transplantation and discuss common health problems encountered in the posttransplant patient.
منابع مشابه
Review of Natural History, Benefits and Risk Factors Pediatric Liver Transplantation
Liver or hepatic transplantation (LT) is the replacement of a diseased liver with part or whole healthy liver from another person (allograft). Human liver transplants were first performed by Thomas Starzl in the United States and Roy Calne in Cambridge, England in 1963 and 1967, respectively. Liver transplantation is a viable treatment option for end-stage liver disease and acute liver failure....
متن کاملContrast Enhanced Echocardiography for Detection of Intrapulmonary Shunts in Liver Transplant Candidates
Background: Intrapulmonary vascular abnormalities associated with liver cirrhosis may result in intrapulmonary right-to-left shunt and hypoxemia. The aim of this study was to use contrast enhanced echocardiography to detect intrapulmonary vascular abnormalities in patients with liver cirrhosis candidates for liver transplantation. Methods: One hundred and two adult patients underwent contrast e...
متن کاملA case of portal vein arterialization after a liver transplant.
Hepatic artery thrombosis represents a potentially deadly complication after a liver transplant. Portal vein arterialization recently has been proposed as a bridge approach in patients with hepatic artery thrombosis needing a retransplant. We report the case of a 53-year-old man treated with a liver transplant for a cryptogenetic cirrhosis. One month after a liver transplant, a hepatic artery t...
متن کاملHepatocellular Adenoma Presenting as a Focal Liver Lesion in Cirrhosis
Hepatocellular adenoma is a benign neoplasm that almost always occurs in a histologically normal liver. We report the finding of a hepatocellular adenoma in the cirrhotic liver of a 56year-old female patient. A hypervascular nodule was detected by computed tomography (CT) scan and magnetic resonance imaging (MRI) conducted as part of a pre-transplant evaluation. The patient subsequently underwe...
متن کاملABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report
Herein, we describe an extremely rare experience of a patient with liver cirrhosis from hepatitis C virus (LC-HCV) who underwent an ABO-incompatible living donor liver transplantation (ABO-I-LDLT) using a hepatitis B core antibody (HBc-Ab) positive donor's liver graft. A 47-year-old Japanese woman with end stage LC-HCV, as a recipient, was preoperatively administered rituximab, mycophenolate mo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2007